Obesity

Latest News

Weight loss medication | Image Credit: alones - stock.adobe.com
Evernorth Launches Co-Pay Cap for Weight Loss Drugs Amid New Federal Drug Pricing Effort

May 22nd 2025

Evernorth has capped antiobesity drug monthly co-pays at $200 in a move to improve access and affordability amid new drug pricing initiatives.

Obesity highlighted on page | Image credit: Feng Yu – stock.adobe.com
5 Ways the US Obesity Landscape Strays From the Global Picture

May 16th 2025

Semaglutide injectors. | Image Credit :Andreas Prott- stock.adobe.com .jpeg
Novo Nordisk Expands GLP-1 Access Through Telehealth Providers

May 1st 2025

Health inequities concept | Image Credit: © hafakot-stock.adobe.com
Access to Semaglutide, Tirzepatide for Obesity Not Equal for All

April 29th 2025

glp-1 Wegovy, semaglutide | Image credit: Patrick Bay Damsted - stock.adobe.com
Can Medicare Sustain Widespread Access to GLP-1 Therapies?

April 25th 2025

Continuing Medical Education
View All
May 24th 2025

Novel Therapies and Emerging Strategies for HR+/HER2- Metastatic Breast Cancer and the Impact on Patient Outcomes

1.5 Credits / Oncology, Breast Cancer
May 24th 2025

Application of Recent Data in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Managed Care Insights and Strategies

1.5 Credits / Ophthalmology, Optometry
May 24th 2025

Emerging Concepts and Approaches in the Treatment of Food Allergy: What Managed Care Professionals Need to Know

1.5 Credits / Immunology, Allergy
May 24th 2025

Addressing the Gaps and Clinical Challenges in Chronic Lymphocytic Leukemia: Updates and Strategies for Managed Care

1.5 Credits / Hematology, Hematologic Cancer, Oncology
May 24th 2025

Keeping Pace With New Developments in Multiple Myeloma: Updates and Strategies to Optimize Bispecific Antibodies and CAR T-Cell Therapy

1.5 Credits / Oncology, Hematology, Hematologic Cancer
May 24th 2025

Leveraging Novel Therapies to Transform Demodex Blepharitis Care

May 13, 2025 | 7:00 PM ET
May 24th 2025

Novel Agents as Proactive Approaches to Addressing Food Allergy: The Role of the Pharmacist in Guiding Optimal Treatment

1.5 Credits / Allergy
May 24th 2025

Patient-Centered Treatment Plans for Management of Neovascular (Wet) AMD and Diabetic Macular Edema: Insights on Recent Efficacy, Safety, and Real-World Data to Improve Adherence and Outcomes

1.5 Credits / Ophthalmology/Optometry
May 24th 2025

Innovations in Inflammatory Bowel Disease Therapy: How IL-23 Inhibitors Are Shaping Treatment and Managed Care Approaches

May 20, 2025 | 1:00 PM and 8:00 PM ET
May 24th 2025

Navigating Next-Generation Therapies for the Management of Acid-Related Disorders

1.5 Credits / Gastroenterology
May 24th 2025

Exploring Transthyretin-Mediated Amyloidosis and Its Phenotypes: A Comprehensive Approach to Patient Treatment

1.5 Credits / Cardiology, Neurology, Rare Diseases
May 24th 2025

Exploring Innovative Approaches in Myasthenia Gravis and the Specialty Pharmacist’s Role in Optimizing Value-Based Treatment

1.5 Credits / Immunology
May 24th 2025

Leveraging Novel Therapies to Transform Demodex Blepharitis Care (6/11)

Jun 11, 2025 1:00 PM ET
May 24th 2025

Navigating the HIV Treatment Frontier: Equipping Managed Care Professionals With Strategies for Innovation, Access, and Adherence

1.5 Credits / HIV/AIDS, Infectious Diseases
May 24th 2025

Integrating Multi-Cancer Early Detection Tests Into Clinical Practice: The Health Economics Perspective for Managed Care Professionals

1.5 Credits / Oncology
May 24th 2025

Treatment Gaps in the Management of Generalized Pustular Psoriasis: Enhancing the Role of Managed Care

1.5 Credits / Dermatology, Immunology
May 24th 2025

Advancing Patient Outcomes in Hidradenitis Suppurativa: Updates and Strategies for Managed Care

1.5 Credits / Dermatology
May 24th 2025

The Role of the Specialty Pharmacist in Optimizing Treatment for Amyotrophic Lateral Sclerosis: The Impact of Early Intervention, Patient-Centered Care, and Disease-Modifying Therapies in Slowing Disease Progression

1.0 Credit / Neurology
May 24th 2025

Advancing Targeted Therapies Aimed at Smoldering Disease in Multiple Sclerosis

1.0 Credit / Immunology, Neurology
May 24th 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
May 24th 2025

The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmacist Credit)

2.0 Credits / Human Trafficking, Law
May 24th 2025

Managed Care Insights on the Advances in the Eosinophilic Esophagitis Treatment Landscape

1.0 Credit / Gastroenterology, Immunology, Rare Diseases
May 24th 2025

An American Journal of Managed Care® Forum: Discussing the Expanding Targeted Therapy Options and Complexities in Metastatic HER2+ Breast Cancer Treatment

1.5 Credits / Breast Cancer, Oncology
May 24th 2025

Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies

1.0 Credit / Immunology, Pulmonology/Respiratory
May 24th 2025

Managed Care Approaches to Individualize Treatment of Hereditary Angioedema

1.0 Credit / Immunology
May 24th 2025

Prescription Digital Therapeutics in Schizophrenia: A Managed Care Perspective on Advancements

2.0 Credits / Psychiatry
May 24th 2025

Navigating Innovations: A Managed Care Perspective Addressing the Economic Burden of Schizophrenia

3.0 Credits / Psychiatry
May 24th 2025

From Strict Avoidance to Tailored Therapies: Transforming Food Allergy Care

1.5 Credits / Allergy, Immunology
May 24th 2025

The Evolving Strategies for Managing nAMD and DME: Empowering Managed Care Decisions for Improved Patient Outcomes

1.5 Credits / Endocrinology, Diabetes & Metabolism, Ophthalmology/Optometry
May 24th 2025

Managing Schizophrenia: Evidence-Based Care and Optimizing Value of New and Emerging Therapies

1.0 Credit / Psychiatry

More News

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo